Literature DB >> 30235181

Notes from the Field: Responding to an Outbreak of Monkeypox Using the One Health Approach - Nigeria, 2017-2018.

Womi-Eteng Eteng, Anna Mandra, Jeff Doty, Adesola Yinka-Ogunleye, Sola Aruna, Mary G Reynolds, Andrea M McCollum, Whitni Davidson, Kimberly Wilkins, Muhammad Saleh, Oladipupo Ipadeola, Lamin Manneh, Uchenna Anebonam, Zainab Abdulkareem, Nma Okoli, Jeremiah Agenyi, Chioma Dan-Nwafor, Ibrahim Mahmodu, Chikwe Ihekweazu.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30235181      PMCID: PMC6147416          DOI: 10.15585/mmwr.mm6737a5

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
On September 22, 2017, a suspected human case of monkeypox was reported to the Nigeria Centre for Disease Control (NCDC) from Bayelsa State in southern Nigeria. Because monkeypox had not been reported in Nigeria since 1978 (), the case raised national and international concern. A multisectoral, international outbreak investigation was undertaken to identify sources and risk factors, establish surveillance, and enhance preparedness. A suspected case was defined as the sudden onset of fever, followed by a vesiculopustular rash primarily on the face, palms, and soles. A confirmed case was any suspected case with laboratory confirmation (by serology, molecular detection of viral DNA, or virus isolation). A probable case was a suspected case epidemiologically linked to a confirmed case. As of February 25, 2018, a total of 228 suspected cases (including 89 confirmed and three probable cases) had been investigated in 24 of Nigeria’s 36 states and the Federal Capital Territory. Six deaths (6.7%) were recorded among the 89 confirmed cases. The outbreak has not been declared over, and NCDC continues to collect data to develop a baseline level for this disease, which had not been reported in 40 years and now might be endemic to Nigeria. Given the zoonotic nature of the disease, this outbreak has required a robust One Health outbreak collaboration among human, animal, and environmental health institutions. Monkeypox virus is a zoonotic orthopoxvirus. Although the animal reservoir is not known, small mammals appear to play a role in the circulation of the virus in nature (). Monkeypox virus can be transmitted to humans through bites and direct contact with infected animals, including during preparation of meat, and case fatality rates can reach 10%. Currently no drugs are licensed for treatment of monkeypox; smallpox vaccine, which historically demonstrated approximately 85% protection against monkeypox, has not been in widespread use since the eradication of smallpox in 1980 (,). A multiagency interdisciplinary emergency operations center (EOC) was activated on October 9, 2017; the EOC facilitated joint epidemiologic investigations, targeted risk communication, and developed laboratory diagnostic capacity for human and animal specimens.* An incident action plan and interim national guidelines were developed, and a protocol for active monkeypox surveillance in animals was developed, targeting high-risk areas at the human-animal interface, such as markets that sell bush meat (meat from nondomesticated animals hunted for food), wildlife parks, zoos, and farms. To enhance laboratory diagnostic capacity, personnel from the NCDC National Reference Laboratory and the National Veterinary Research Institute received training in monkeypox molecular diagnosis. Joint human and animal health teams conducted field investigations to study the human, animal, and environmental sources of infection, as well as risk factors and modes of transmission. Human-to-human transmission was presumed in a limited number of cases through investigation into clusters (within individual households) of confirmed cases. A human-to-human transmission chain was presumed when symptom onset occurred in a close contact of a confirmed case at an interval consistent with the incubation period of 5–13 days. Most cases could not be epidemiologically linked, suggesting a multisource outbreak or previously undetected endemic transmission. Links to zoonotic origin also could not be determined, and the role of environmental factors is not known. Further institutional collaboration for research in these areas has been identified. The communications team developed and implemented a plan focused on alleviating public fear and anxiety regarding this largely unknown disease. Key messages, health advisories, frequently asked questions, press releases, and a risk communication activity tracker were formulated in collaboration with animal health partners with contents addressing possible risk factors identified during the investigation. Key messages included avoiding physical contact with persons infected with monkeypox, avoiding contact with wild animals (especially those found dead), cooking animal food products thoroughly before consumption, frequent handwashing, and early medical evaluation of persons with compatible signs or symptoms. This outbreak likely resulted from a complex intersection of events and, given the zoonotic nature of the disease, required a robust outbreak response collaboration among human, animal, and environmental health institutions. The Economic Community of West African States, in partnership with its member states, has in the past adopted a One Health multidisciplinary approach to human, animal, and environmental health in implementing outbreak response and preparedness, surveillance, communications, coordination, and epidemiologic investigations (). This method facilitates efficient use of scarce resources and leverages various sectors’ capabilities. The response to this outbreak demonstrates the utility of multisectoral collaboration for the investigation and control of zoonotic disease outbreaks. As is best practice in emergency management models, an after-action review involving all partners will be critical in upholding successes, addressing weaknesses, and preparing for future outbreaks.
  3 in total

Review 1.  Outbreaks of human monkeypox after cessation of smallpox vaccination.

Authors:  Mary G Reynolds; Inger K Damon
Journal:  Trends Microbiol       Date:  2012-01-10       Impact factor: 17.079

2.  Human monkeypox: a study of 2,510 contacts of 214 patients.

Authors:  Z Jezek; S S Marennikova; M Mutumbo; J H Nakano; K M Paluku; M Szczeniowski
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

3.  Assessing Monkeypox Virus Prevalence in Small Mammals at the Human-Animal Interface in the Democratic Republic of the Congo.

Authors:  Jeffrey B Doty; Jean M Malekani; Lem's N Kalemba; William T Stanley; Benjamin P Monroe; Yoshinori U Nakazawa; Matthew R Mauldin; Trésor L Bakambana; Tobit Liyandja Dja Liyandja; Zachary H Braden; Ryan M Wallace; Divin V Malekani; Andrea M McCollum; Nadia Gallardo-Romero; Ashley Kondas; A Townsend Peterson; Jorge E Osorio; Tonie E Rocke; Kevin L Karem; Ginny L Emerson; Darin S Carroll
Journal:  Viruses       Date:  2017-10-03       Impact factor: 5.048

  3 in total
  13 in total

1.  Nanopore sequencing of a monkeypox virus strain isolated from a pustular lesion in the Central African Republic.

Authors:  Mathias Vandenbogaert; Aurélia Kwasiborski; Ella Gonofio; Stéphane Descorps-Declère; Benjamin Selekon; Andriniaina Andy Nkili Meyong; Rita Sem Ouilibona; Antoine Gessain; Jean-Claude Manuguerra; Valérie Caro; Emmanuel Nakoune; Nicolas Berthet
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

2.  Monkeypox Outbreak - Nine States, May 2022.

Authors:  Faisal S Minhaj; Yasmin P Ogale; Florence Whitehill; Jordan Schultz; Mary Foote; Whitni Davidson; Christine M Hughes; Kimberly Wilkins; Laura Bachmann; Ryan Chatelain; Marisa A P Donnelly; Rafael Mendoza; Barbara L Downes; Mellisa Roskosky; Meghan Barnes; Glen R Gallagher; Nesli Basgoz; Victoria Ruiz; Nang Thu Thu Kyaw; Amanda Feldpausch; Amy Valderrama; Francisco Alvarado-Ramy; Chad H Dowell; Catherine C Chow; Yu Li; Laura Quilter; John Brooks; Demetre C Daskalakis; R Paul McClung; Brett W Petersen; Inger Damon; Christina Hutson; Jennifer McQuiston; Agam K Rao; Ermias Belay; Andrea M McCollum
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-06-10       Impact factor: 35.301

3.  The new face of monkeypox virus: an emerging global emergency.

Authors:  Nityanand Jain; Edouard Lansiaux; Raimonds Simanis
Journal:  New Microbes New Infect       Date:  2022-05-27

4.  A game-theoretic model of Monkeypox to assess vaccination strategies.

Authors:  Sri Vibhaav Bankuru; Samuel Kossol; William Hou; Parsa Mahmoudi; Jan Rychtář; Dewey Taylor
Journal:  PeerJ       Date:  2020-06-22       Impact factor: 2.984

5.  Reviewing Health Security Capacities in Nigeria Using the Updated WHO Joint External Evaluation and WHO Benchmarks Tool: Experience from a Country-Led Self-Assessment Exercise.

Authors:  Olukayode Fasominu; Oyeladun Okunromade; Oyeronke Oyebanji; Christopher T Lee; Adejare Atanda; Ibrahim Mamadu; Ifeanyi Okudo; Ebere Okereke; Elsie Ilori; Chikwe Ihekweazu
Journal:  Health Secur       Date:  2022-01-11

6.  Travel-Related Monkeypox Outbreaks in the Era of COVID-19 Pandemic: Are We Prepared?

Authors:  Oyelola A Adegboye; Maria Eugenia Castellanos; Faith O Alele; Anton Pak; Henry C Ezechukwu; Kay Hou; Theophilus I Emeto
Journal:  Viruses       Date:  2022-06-13       Impact factor: 5.818

7.  Recent advances in the diagnosis monkeypox: implications for public health.

Authors:  Matthew W McCarthy
Journal:  Expert Rev Mol Diagn       Date:  2022-08-24       Impact factor: 5.670

Review 8.  Monkeypox: A Contemporary Review for Healthcare Professionals.

Authors:  Boghuma K Titanji; Bryan Tegomoh; Saman Nematollahi; Michael Konomos; Prathit A Kulkarni
Journal:  Open Forum Infect Dis       Date:  2022-06-23       Impact factor: 4.423

9.  Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018.

Authors:  Nicolas Berthet; Stéphane Descorps-Declère; Camille Besombes; Manon Curaudeau; Andriniaina Andy Nkili Meyong; Benjamin Selekon; Ingrid Labouba; Ella Cyrielle Gonofio; Rita Sem Ouilibona; Huguette Dorine Simo Tchetgna; Maxence Feher; Arnaud Fontanet; Mirdad Kazanji; Jean-Claude Manuguerra; Alexandre Hassanin; Antoine Gessain; Emmanuel Nakoune
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.996

Review 10.  Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Authors:  Eskild Petersen; Ibrahim Abubakar; Chikwe Ihekweazu; David Heymann; Francine Ntoumi; Lucille Blumberg; Danny Asogun; Victor Mukonka; Swaib Abubaker Lule; Matthew Bates; Isobella Honeyborne; Sayoki Mfinanga; Peter Mwaba; Osman Dar; Francesco Vairo; Maowia Mukhtar; Richard Kock; Timothy D McHugh; Giuseppe Ippolito; Alimuddin Zumla
Journal:  Int J Infect Dis       Date:  2018-11-16       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.